Dr. Anke Smits

Dr. Smits obtained her PhD at the department of exp. Cardiology at the UMCU. Here, she investigated cardiac-tissue derived progenitor cells and their ability to become cardiac cell types in vitro and in vivo. As a post-doc, she joined the cardiovascular cell biology group in the LUMC to to continue this research. A Rubicon fellowship allowed her to join the lab of Prof. Riley at University College London/ Oxford University to learn more about the potential of epicardial-derived cells in cardiac. She returned to the LUMC in 2013 and continued to study cardiac (progenitor) cells and their endogenous repair capacity, funded by a NWO-VENI, and a LUMC Research fellowship. In 2017, she was awarded a Dutch Heart foundation- Dekker grant to expand her research group as an assistant professor focusing on the epicardium and local application of stimulants. Additionally, she is a member of the DEC (Animal ethichs committee), served as a board member of the European Society of Cardiology’s Scientists of Tomorrow, and is currently on the board of the Dutch Young@Heart to help secure the future of young cardiovascular scientists. As a cardiovascular cell biologist, Dr. Smits is interested in cells that can contribute to repair of the injured heart. She focuses on cell-based therapies, and on stimulation of endogenous cells with reparative capacity, with a specific interest in the epicardium. Cell-based therapy includes the delivery of cells or cell-derived products that can contribute to repair of the injured myocardium via e.g. direct differentiation, paracrine mechanisms, or matrix remodelling. Dr. Smits focuses on the identification of an optimal cell (product) to stimulate reparative capacity of the heart. To this end, she combines cell and tissue culture methods with pre-clinical models for e.g. myocardial infarction, and state-of-the-art small animal imaging modules.

Most recent publications

Editorial: Novel strategies to repair the infarcted heart, volume II
Smits AM, Bollini S and Gladka MM
Editorial: Straight from the heart: Novel insights and future perspectives for cardiac repair
Bollini S, Gladka MM and Smits AM
Chasing youth on the outside: unique features of the human fetal epicardium
Smits AM and Goumans MJ
Single-cell analysis of human fetal epicardium reveals its cellular composition and identifies CRIP1 as a modulator of EMT
Streef TJ, Groeneveld EJ, van Herwaarden T, Hjortnaes J, Goumans MJ and Smits AM
The epicardium plays an essential role in cardiogenesis by providing cardiac cell types and paracrine cues to the developing myocardium. The human adult epicardium is quiescent, but recapitulation of developmental features may contribute to adult cardiac repair. The cell fate of epicardial cells is proposed to be determined by the developmental persistence of specific subpopulations. Reports on this epicardial heterogeneity have been inconsistent, and data regarding the human developing epicardium are scarce. Here we specifically isolated human fetal epicardium and used single-cell RNA sequencing to define its composition and to identify regulators of developmental processes. Few specific subpopulations were observed, but a clear distinction between epithelial and mesenchymal cells was present, resulting in novel population-specific markers. Additionally, we identified CRIP1 as a previously unknown regulator involved in epicardial epithelial-to-mesenchymal transition. Overall, our human fetal epicardial cell-enriched dataset provides an excellent platform to study the developing epicardium in great detail.
Cryopreservation of Human Adult Ventricular Tissue for the Preparation of Viable Myocardial Slices
Lodrini AM, Groeneveld EJ, Palmen M, Hjortnaes J, Smits AM and Goumans MJ
Living myocardial slices (LMS) are ultrathin sections of adult myocardium that can be maintained in culture. These slices provide a unique platform for studying interactions between cardiomyocytes (CMs), other cardiac cell types, and the extracellular matrix while maintaining the cytoarchitecture and electrical phenotype of CMs over extended periods. Despite their advantages over other cardiac models, LMS have limitations, particularly their reliance on slice quality. The primary factor influencing the quality of the slices is the method used to process the cardiac tissue block. Current methods typically require immediate slice preparation following the excision of the tissue block, which restricts the timing of experiments. To address this limitation, we developed a simple procedure for cryopreserving human adult myocardium, allowing the preparation of LMS at a later stage. The protocol provides a list of required equipment and reagents, as well as a detailed description of the methodology for processing the myocardium and slice preparation. We present typical results demonstrating that cryopreserved human cardiac tissue retains biomass and structural integrity comparable to freshly obtained myocardium. Furthermore, we assessed the LMS derived from both fresh and cryopreserved samples. Histological analysis confirmed the preservation of viability, normal cytomorphology, and gap junctions between CMs in all LMS after 24 h and up to 5 days of culture in the absence of electrical stimulation. Cryopreservation extends the interval between tissue collection and LMS preparation, facilitating longer-term and more complex experiments. Further research into the impact of cryopreservation on various cardiac cell types will promote better donor organ management and efficient banking of cardiac samples from a multitude of donors and disease states. © 2024 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: Preparation and preservation of human adult myocardium Basic Protocol 2: Preparation of adult living myocardial slices from cryopreserved blocks.